Lisa Vandermeer

1.6k total citations
108 papers, 1.1k citations indexed

About

Lisa Vandermeer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lisa Vandermeer has authored 108 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 33 papers in Cancer Research. Recurrent topics in Lisa Vandermeer's work include Breast Cancer Treatment Studies (30 papers), Bone health and treatments (29 papers) and Cancer Treatment and Pharmacology (20 papers). Lisa Vandermeer is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Bone health and treatments (29 papers) and Cancer Treatment and Pharmacology (20 papers). Lisa Vandermeer collaborates with scholars based in Canada, United States and Saudi Arabia. Lisa Vandermeer's co-authors include Mark Clemons, Sasha Mazzarello, Brian Hutton, John Hilton, Nathaniel Bouganim, Susan Dent, Carol Stober, Dean Fergusson, Mark Clemons and Gregory R. Pond and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Lisa Vandermeer

101 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Vandermeer Canada 18 572 287 234 161 151 108 1.1k
Jennifer Sung United States 22 356 0.6× 307 1.1× 231 1.0× 82 0.5× 65 0.4× 46 1.6k
Ahmet Özet Türkiye 19 499 0.9× 144 0.5× 301 1.3× 120 0.7× 96 0.6× 153 1.3k
Olufemi J. Ogunbiyi Nigeria 19 456 0.8× 241 0.8× 311 1.3× 134 0.8× 189 1.3× 70 1.8k
Caitlin C Morrison United States 9 790 1.4× 440 1.5× 272 1.2× 194 1.2× 97 0.6× 17 1.5k
Aya Mitani United States 20 336 0.6× 270 0.9× 295 1.3× 81 0.5× 92 0.6× 60 1.2k
Monica Khunger United States 15 598 1.0× 121 0.4× 582 2.5× 55 0.3× 71 0.5× 36 1.4k
Jeong-Soo Im South Korea 10 391 0.7× 184 0.6× 294 1.3× 85 0.5× 86 0.6× 19 988
Véronique Girre France 13 556 1.0× 149 0.5× 291 1.2× 234 1.5× 89 0.6× 21 1.1k
Yvonne H. Sada United States 16 381 0.7× 252 0.9× 278 1.2× 159 1.0× 82 0.5× 54 1.5k
Hikmat Abdel‐Razeq Jordan 17 481 0.8× 118 0.4× 195 0.8× 235 1.5× 134 0.9× 155 1.2k

Countries citing papers authored by Lisa Vandermeer

Since Specialization
Citations

This map shows the geographic impact of Lisa Vandermeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Vandermeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Vandermeer more than expected).

Fields of papers citing papers by Lisa Vandermeer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Vandermeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Vandermeer. The network helps show where Lisa Vandermeer may publish in the future.

Co-authorship network of co-authors of Lisa Vandermeer

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Vandermeer. A scholar is included among the top collaborators of Lisa Vandermeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Vandermeer. Lisa Vandermeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGee, Sharon F., Mark Clemons, Gregory R. Pond, et al.. (2024). A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current Oncology. 31(8). 4531–4545. 2 indexed citations
2.
Clemons, Mark, Lisa Vandermeer, Khaled El Emam, et al.. (2024). The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current Oncology. 31(3). 1376–1388.
3.
Hilton, John, et al.. (2023). Regularly scheduled physical examinations and the detection of breast cancer recurrences. The Breast. 69. 274–280. 10 indexed citations
4.
Mitsakakis, Nicholas, Gregory R. Pond, Lisa Vandermeer, et al.. (2023). Can synthetic data accurately mimic oncology clinical trials?. Journal of Clinical Oncology. 41(16_suppl). 1554–1554. 2 indexed citations
5.
Fernandes, Ricardo, Terry L. Ng, Jacques Raphael, et al.. (2023). A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer. Current Oncology. 30(8). 7384–7397. 3 indexed citations
6.
7.
8.
9.
Dent, Susan, Dean Fergusson, Olexiy Aseyev, et al.. (2021). A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer. Current Oncology. 28(6). 5073–5083. 6 indexed citations
10.
Ng, Terry L., Megan M. Tu, Mohammed Ibrahim, et al.. (2020). Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Supportive Care in Cancer. 29(2). 925–943. 31 indexed citations
11.
Clemons, Mark, Lisa Vandermeer, Arif Awan, et al.. (2020). Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey. Journal of bone oncology. 26. 100339–100339. 11 indexed citations
12.
Awan, Arif, Andrew Robinson, Carol Stober, et al.. (2019). A prospective, multicentre, randomized trial comparing vascular access strategies for patients receiving non-trastuzumab containing chemotherapy for early stage breast cancer. Annals of Oncology. 30. iii66–iii67. 1 indexed citations
13.
Fernandes, Ricardo, Sasha Mazzarello, Anil A. Joy, et al.. (2018). Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study. Supportive Care in Cancer. 26(9). 3073–3081. 14 indexed citations
14.
Thavorn, Kednapa, Doug Coyle, Jeffrey S. Hoch, et al.. (2017). A cost-utility analysis of risk model-guided versus physician’s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach. Supportive Care in Cancer. 25(8). 2505–2513. 5 indexed citations
15.
Dudani, Shaan, Sasha Mazzarello, John Hilton, et al.. (2016). Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review. Clinical Breast Cancer. 16(6). 456–470. 22 indexed citations
16.
Dranitsaris, George, Sasha Mazzarello, Stephanie Smith, et al.. (2015). Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors. Supportive Care in Cancer. 24(4). 1563–1569. 16 indexed citations
17.
Addison, Christina, Nathaniel Bouganim, John Hilton, et al.. (2014). A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events. Breast Cancer Research and Treatment. 144(3). 615–624. 21 indexed citations
18.
Kuchuk, Iryna, Nathaniel Bouganim, Lisa Vandermeer, et al.. (2013). Patient perceptions about potential side effects and benefits from chemotherapy agents.. Journal of Clinical Oncology. 31(15_suppl). 6595–6595. 6 indexed citations
19.
Fralick, Michael, Nathaniel Bouganim, Richard Kremer, et al.. (2012). Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients–preliminary results. Journal of bone oncology. 1(3). 69–73. 8 indexed citations
20.
Hilton, John, Lisa Vandermeer, Sean Hopkins, et al.. (2011). A multicenter study assessing 12-weekly intravenous bisphosphonate therapy in women with low-risk bone metastases from breast cancer: The TRIUMPH trial.. Journal of Clinical Oncology. 29(15_suppl). TPS242–TPS242. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Sung Breakdown of academic impact, for papers by Ahmet Özet Breakdown of academic impact, for papers by Olufemi J. Ogunbiyi Breakdown of academic impact, for papers by Caitlin C Morrison Breakdown of academic impact, for papers by Aya Mitani Breakdown of academic impact, for papers by Monica Khunger Breakdown of academic impact, for papers by Jeong-Soo Im Breakdown of academic impact, for papers by Véronique Girre Breakdown of academic impact, for papers by Yvonne H. Sada Breakdown of academic impact, for papers by Hikmat Abdel‐Razeq
Rankless by CCL
2026